Excessive daytime sleepiness in adolescents: current treatment strategies

Matthieu Hein; Anais Mungo; Philippe Hubain; Gwenolé Loas

doi:10.5935/1984-0063.20190143

Sleep Science, Table of Contents

CC BY-NC-ND 4.0 · Sleep Sci 2020; 13(02): 157-171
DOI: 10.5935/1984-0063.20190143

REVIEWS

Excessive daytime sleepiness in adolescents: current treatment strategies

Matthieu Hein

¹Erasme Hospital, Université Libre de Bruxelles, ULB, Department of Psychiatry and Sleep Laboratory - Anderlecht - Bruxelles - Belgium.

,

Anais Mungo

¹Erasme Hospital, Université Libre de Bruxelles, ULB, Department of Psychiatry and Sleep Laboratory - Anderlecht - Bruxelles - Belgium.

,

Philippe Hubain

¹Erasme Hospital, Université Libre de Bruxelles, ULB, Department of Psychiatry and Sleep Laboratory - Anderlecht - Bruxelles - Belgium.

,

Gwenolé Loas

¹Erasme Hospital, Université Libre de Bruxelles, ULB, Department of Psychiatry and Sleep Laboratory - Anderlecht - Bruxelles - Belgium.

› Author Affiliations

Abstract

ABSTRACT

The complaints of excessive daytime sleepiness are very common among adolescents. In addition, in this particular subpopulation, the presence of excessive daytime sleepiness is associated with negative impact on school performances, interpersonal difficulties (school friends or family), extracurricular activities, health and driving. In adolescents with complaints of excessive daytime sleepiness, it is important to perform a complete clinical assessment including systematic clinical interview, physical examination, sleep diaries, use of specific questionnaires and possible confirmatory tests. In adolescents, the main causes of excessive daytime sleepiness are sleep deprivation, inadequate sleep hygiene, insomnia disorders, circadian rhythm disorders, chronic somatic pathologies, psychiatric disorders, movement disorders related to sleep, respiratory disorders related to sleep, parasomnias, hypersomnia disorders and use of drugs or medications. Given the multiple aetiologies of excessive daytime sleepiness in adolescents, the implementation of targeted therapeutic strategies is essential in order to allow optimal management of this symptom and better prevention of its negative consequences. The aim of this review is therefore to provide health care professionals caring for adolescents with excessive daytime sleepiness complaints the currently recommended therapeutic strategies for the main aetiologies of excessive daytime sleepiness in this particular subpopulation.

Keywords:

Adolescent - Sleepiness - Therapeutic Approaches - Sleep

Full Text

References

REFERENCES
1 Shahid A, Shen J, Shapiro CM. Measurements of sleepiness and fatigue. J Psychosom Res. 2010;69(1):81-9.
2 Shen J, Barbera J, Shapiro CM. Distinguishing sleepiness and fatigue: focus on definition and measurement. Sleep Med Rev. 2006;10(1):63-76.
3 Gibson ES, Powles AC, Thabane L, O'Brien S, Molnar DS, Trajanovic N, et al. "Sleepiness" is serious in ado-lescence: two surveys of 3235 Canadian students. BMC Public Health. 2006;6:116.
4 Fatani A, Al-Rouqi K, Al Towairky J, Ahmed AE, Al-Jahdali S, Ali Y, et al. Effect of age and gender in the pre-valence of excessive daytime sleepiness among a sample of the Saudi population. J Epidemiol Glob Health. 2015;5(4 Suppl 1):S59-66.
5 Hawley CJ, Gale TM, Sivakumaran T, Paul S, Kondan VR, Farag A, et al. Excessive daytime sleepiness in psychiatric disorders: prevalence, correlates and clinical significance. Psychiatry Res. 2010;175(1-2):138-41.
6 Souza JC, Magna LA, Reimão R. Excessive daytime sleepiness in Campo Grande general population, Brazil. Arq Neuro-Psiquiatr. 2002;60(3A):558-62.
7 Drake C, Nickel C, Burduvali E, Roth T, Jefferson C, Pietro B. The Pediatric Daytime Sleepiness Scale (PDSS): sleep habits and school outcomes in middle-school children. Sleep. 2003;26(4):455-8.
8 Perez-Chada D, Perez-Lloret S, Videla AJ, Cardinali D, Bergna MA, Fernández-Acquier M, et al. Sleep disor-dered breathing and daytime sleepiness are associated with poor academic performance in teenagers. A study using the Pediatric Daytime Sleepiness Scale (PDSS). Sleep. 2007;30(12):1698-703.
9 Perez-Lloret S, Videla AJ, Richaudeau A, Vigo D, Rossi M, Cardinali DP, et al. A multi-step pathway connec-ting short sleep duration to daytime somnolence, reduced attention, and poor academic performance: an exploratory cross sectional study in teenagers. J Clin Sleep Med. 2013;9(5):469-73.
10 Owens J, Adolescent Sleep Working Group; Committee on Adolescence. Insufficient sleep in adolescents and young adults: an update on causes and consequences. Pediatrics. 2014;134(3):e921-32.
11 Shochat T, Cohen-Zion M, Tzischinsky O. Functional consequences of inadequate sleep in adolescents: a systematic review. Sleep Med Rev. 2014;18(1):75-87.
12 Hagenauer MH, Perryman JI, Lee TM, Carskadon MA. Adolescent changes in the homeostatic and circadian regulation of sleep. Dev Neurosci. 2009;31(4):276-84.
13 Carskadon MA, Harvey K, Duke P, Anders TF, Litt IF, Dement WC. Pubertal changes in daytime sleepiness. Sleep. 1980;2(4):453-60.
14 Jenni OG, Carskadon MA. Spectral analysis of the sleep electroencephalogram during adolescence. Sleep. 2004;27(4):774-83.
15 Carskadon MA, Vieira C, Acebo C. Association between puberty and delayed phase preference. Sleep. 1993;16(3):258-62.
16 Taylor DJ, Jenni OG, Acebo C, Carskadon MA. Sleep tendency during extended wakefulness: insights into adolescent sleep regulation and behavior. J Sleep Res. 2005;14(3):239-44.
17 Fallone G, Owens JA, Deane J. Sleepiness in children and adolescents: clinical implications. Sleep Med Rev. 2002;6(4):287-306.
18 Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human li-fespan. Sleep. 2004;27(7):1255-73.
19 Crowley SJ, Wolfson AR, Tarokh L, Carskadon MA. An update on adolescent sleep: new evidence informing the perfect storm model. J Adolesc. 2018;67:55-65.
20 Crowley SJ, Acebo C, Carskadon MA. Sleep, circadian rhythms, and delayed phase in adolescence. Sleep Med. 2007;8(6):602-12.
21 Moore M, Meltzer LJ. The sleepy adolescent: causes and consequences of sleepiness in teens. Paediatr Respir Rev. 2008;9(2):114-21.
22 Hansen SL, Capener D, Daly C. Adolescent sleepiness: causes and consequences. Pediatr Ann. 2017;46(9):e340-e44.
23 Merdad RA, Akil H, Wali SO. Sleepiness in adolescents. Sleep Med Clin. 2017;12(3):415-28.
24 Carrot B, Lecendreux M. Evaluation of excessive daytime sleepiness in child and adolescent psychopatho-logy. Arch Pediatr. 2011;18(8):891-901.
25 Spilsbury JC, Drotar D, Rosen CL, Redline S. The Cleveland adolescent sleepiness questionnaire: a new me-asure to assess excessive daytime sleepiness in adolescents. J Clin Sleep Med. 2007;3(6):603-12.
26 Mouthon AL, Huber R. Methods in pediatric sleep research and sleep medicine. Neuropediatrics. 2015;46(3):159-70.
27 Nevsimalova S. Narcolepsy in childhood. Sleep Med Rev. 2009;13(2):169-80.
28 Franco P, Bourdin H, Braun F, Briffod J, Pin I, Challamel MJ. Overnight polysomnography versus respiratory polygraphy in the diagnosis of pediatric obstructive sleep apnea. Arch Pediatr. 2017;(24 Suppl 1):S16-S27.
29 Newell J, Strauss M, Hein M, Mairesse O, Loas G, Neu D. Medical indications of polysommnography in clini-cal practice. Rev Med Brux. 2020;41(1):26-34.
30 Derry CP. Sleeping in fits and starts: a practical guide to distinguishing nocturnal epilepsy from sleep disor-ders. Pract Neurol. 2014;14(6):391-8.
31 Kothare SV, Kaleyias J. The clinical and laboratory assessment of the sleepy child. Semin Pediatr Neurol. 2008;15(2):61-9.
32 Millman RP, Working Group on Sleepiness in Adolescents/Young Adults; AAP Committee on Adolescence. Excessive sleepiness in adolescents and young adults: causes, consequences, and treatment strategies. Pediatrics. 2005;115(6):1774-86.
33 Short MA, Gradisar M, Wright H, Lack LC, Dohnt H, Carskadon MA. Time for bed: parent-set bedtimes asso-ciated with improved sleep and daytime functioning in adolescents. Sleep. 2011;34(6):797-800.
34 Cain N, Gradisar M. Electronic media use and sleep in school-aged children and adolescents: a review. Sleep Med. 2010;11(8):735-42.
35 Bootzin RR, Stevens SJ. Adolescents, substance abuse, and the treatment of insomnia and daytime sleepi-ness. Clin Psychol Rev. 2005;25(5):629-44.
36 Rossi CM, Campbell AL, Vo OT, Marco CA, Wolfson AR. Middle school sleep-smart program: a pilot evalua-tion. Sleep 2002;25:A279.
37 Sousa IC, Araújo JF, Azevedo CVM. The effect of a sleep hygiene education program on the sleep-wake cycle of Brazilian adolescent students. Sleep Biol Rhythms. 2007;5(4):251-8.
38 Moseley L, Gradisar M. Evaluation of a school-based intervention for adolescent sleep problems. Sleep. 2009;32(3):334-41.
39 Cain N, Gradisar M, Moseley L. A motivational school-based intervention for adolescent sleep problems. Sleep Med. 2011;12(3):246-51.
40 Lufi D, Tzischinsky O, Hadar S. Delaying school starting time by one hour: some effects on attention levels in adolescents. J Clin Sleep Med. 2011;7:137-43.
41 Hershner SD, Chervin RD. Causes and consequences of sleepiness among college students. Nat Sci Sleep. 2014;6:73-84.
42 Morin CM, Vallières A, Guay B, Ivers H, Savard J, Mérette C, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009;301(19):2005-15.
43 Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life in-somnia: a randomized controlled trial. JAMA. 1999;281(11):991-9.
44 Donskoy I, Loghmanee D. Insomnia in adolescence. Med Sci (Basel). 2018;6(3):E72.
45 Mitchell MD, Gehrman P, Perlis M, Umscheid CA. Comparative effectiveness of cognitive behavioral the-rapy for insomnia: a systematic review. BMC Fam Pract. 2012;13:40.
46 Hein M, Hubain P, Linkowski P, Loas G. Support for insomnia: recommendations for practice in general me-dicine. Rev Med Brux. 2016;37(4):235-41.
47 Williams J, Roth A, Vatthauer K, McCrae C. Cognitive behavioral treatment of insomnia. Chest. 2013;143(2):554-65.
48 Morgenthaler T, Kramer M, Alessi C, Friedman L, Boehlecke B, Brown T, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American academy of sleep medicine report. Sleep. 2006;29(11):1415-9.
49 Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine Clinical Practice Guide-line. J Clin Sleep Med. 2017;13:307-49.
50 Blake MJ, Sheeber LB, Youssef GJ, Raniti MB, Allen NB. Systematic review and meta-analysis of adolescent cognitive-behavioral sleep interventions. Clin Child Fam Psychol Rev. 2017;20(3):227-49.
51 Ma ZR, Shi LJ, Deng MH. Efficacy of cognitive behavioral therapy in children and adolescents with insomnia: a systematic review and meta-analysis. Braz J Med Biol Res. 2018;51(6):e7070.
52 Petrov MER, Lichstein KL, Huisingh CE, Bradley LA. Predictors of adherence to a brief behavioral insomnia intervention: daily process analysis. Behav Ther. 2014;45(3):430-42.
53 Owens JA, Babcock D, Blumer J, Chervin R, Ferber R, Goetting M, et al. The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: rational approaches. A consensus meeting summary. J Clin Sleep Med. 2005;1(1):49-59.
54 Owens JA, Moturi S. Pharmacologic treatment of pediatric insomnia. Child Adolesc Psychiatr Clin N Am. 2009;18(4):1001-16.
55 Weiss SK, Garbutt A. Pharmacotherapy in pediatric sleep disorders. Adolesc Med State Art Rev. 2010;21(3):508-21.
56 Owens JA, Rosen CL, Mindell JA, Kirchner HL. Use of pharmacotherapy for insomnia in child psychiatry prac-tice: a national survey. Sleep Med. 2010;11(7):692-700.
57 Zambotti M, Goldstone A, Colrain IM, Baker FC. Insomnia disorder in adolescence: diagnosis, impact, and treatment. Sleep Med Rev. 2018;39:12-24.
58 Felt BT, Chervin RD. Medications for sleep disturbances in children. Neurol Clin Pract. 2014;4(1):82-7.
59 Reed MD, Findling RL. Overview of current management of sleep disturbances in children. I - Pharmaco-therapy. Curr Therap Res. 2002;63(Suppl B):B18-37.
60 Palermo TM, Koren G, Blumer JL. Rational pharmacotherapy for childhood sleep disturbances: characteris-tics of an ideal hypnotic. Curr Therap Res 2002;63(Suppl B):B67-79.
61 Gyllenhaal, C, Merritt S, Peterson S, Block K, Gochenour T. Efficacy and safety of herbal stimulants and se-datives in sleep disorders. Sleep Med Rev. 2000;4(3):229-51.
62 Nguyen M, Tharani S, Rahmani M, Shapiro M. A review of the use of clonidine as a sleep aid in the child and adolescent population. Clin Pediatr (Phila). 2014;53(3):211-6.
63 Okamoto H, Iyo M, Ueda K, Han C, Hirasaki Y, Namiki T. Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions. Neuropsychiatr Dis Treat. 2014;10:1727-42.
64 Motoo Y, Seki T, Tsutani K. Traditional Japanese medicine, Kampo: its history and current status. Chin J In-tegr Med. 2011;17(2):85-7.
65 Mizoguchi K, Ikarashi Y. Multiple psychopharmacological effects of the traditional Japanese Kampo Medici-ne Yokukansan, and the brain regions it affects. Front Pharmacol. 2017;8:149.
66 Ogawa Y, Fujii Y, Sugiyama R, Konishi T. The role of the seven crude drug components in the sleep-promoting effect of Yokukansan. J Ethnopharmacol. 2016;177:19-27.
67 Muramatsu S, Aihara M, Shimizu I, Arai M, Kajii E. Current status of Kampo Medicine in community health care. Gen Med. 2012;13(1):37-45.
68 Watanabe K, Matsuura K, Gao P, Hottenbacher L, Tokunaga H, Nishimura K, et al. Traditional Japanese Kampo Medicine: clinical research between modernity and traditional medicine-the state of research and methodological suggestions for the future. Evid Based Complement Alternat Med. 2011;2011:513842.
69 Liu L, Liu C, Wang Y, Wang P, Li Y, Li B. Herbal medicine for anxiety, depression and insomnia. Curr Neu-ropharmacol. 2015;13(4):481-93.
70 Motoo Y, Arai I, Hyodo I, Tsutani K. Current status of Kampo (Japanese herbal) medicines in Japanese clini-cal practice guidelines. Complement Ther Med. 2009;17(3):147-54.
71 Morgenthaler TI, Lee-Chiong T, Alessi C, Friedman L, Aurora RN, Boehlecke B, et al. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. Sleep. 2007;30(11):1445-59.
72 Micic G, Richardson C, Cain N, Reynolds C, Bartel K, Maddock B, et al. Readiness to change and commit-ment as predictors of therapy compliance in adolescents with Delayed Sleep-Wake Phase Disorder. Sleep Med. 2019;55:48-55.
73 Weitzman ED, Czeisler CA, Coleman RM, Spielman AJ, Zimmerman JC, Dement W, et al. Delayed sleep phase syndrome. A chronobiological disorder with sleep-onset insomnia. Arch Gen Psychiatry. 1981;38(7):737-46.
74 Gooley JJ. Treatment of circadian rhythm sleep disorders with light. Ann Acad Med Singapore. 2008;37(8):669-76.
75 Mundey K, Benloucif S, Harsanyi K, Dubocovich ML, Zee PC. Phase-dependent treatment of delayed sleep phase syndrome with melatonin. Sleep. 2005;28(10):1271-8.
76 Bartlett DJ, Biggs SN, Armstrong SM. Circadian rhythm disorders among adolescents: assessment and trea-tment options. Med J Aust. 2013;199(8):S16-20.
77 Barion A, Zee PC. A clinical approach to circadian rhythm sleep disorders. Sleep Med. 2007;8(6):566-77.
78 Kidwell KM, Van Dyk TR, Lundahl A, Nelson TD. Stimulant medications and sleep for youth with ADHD: a meta-analysis. Pediatrics. 2015;136(6):1144-53.
79 Meier PS, Barrowclough C, Donmall MC. The role of the therapeutic alliance in the treatment of substance misuse: a critical review of the literature. Addiction. 2005;100(3):304-16.
80 Mirza K, Mirza S. Adolescent substance misuse. Psychiatry. 2008;7(8):357-62.
81 Kaditis AG, Alonso Alvarez ML, Boudewyns A, Alexopoulos EI, Ersu R, Joosten K, et al. Obstructive sleep di-sordered breathing in 2- to 18-year-old children: diagnosis and management. Eur Respir J. 2016;47(1):69-94.
82 Séailles T, Vecchierini MF. Le syndrome d'apnées obstructives du sommeil (SAOS): particularités chez l'adolescent. Médecine Sommeil. 2012;9(3):110-8.
83 Todd CA, Bareiss AK, McCoul ED, Rodriguez KH. Adenotonsillectomy for obstructive sleep apnea and qua-lity of life: systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2017;157(5):767-73.
84 Brietzke SE, Gallagher D. The effectiveness of tonsillectomy and adenoidectomy in the treatment of pedia-tric obstructive sleep apnea/hypopnea syndrome: a meta- analysis. Otolaryngol Head Neck Surg. 2006;134(6):979-84.
85 Cielo CM, Gungor A. Treatment options for pediatric obstructive sleep apnea. Curr Probl Pediatr Adolesc Health Care. 2016;46(1):27-33.
86 Marcus CL, Brooks LJ, Draper KA, Gozal D, Halbower AC, Jones J, et al. Diagnosis and management of chil-dhood obstructive sleep apnea syndrome. Pediatrics. 2012;130(3):e714-55.
87 Section on Pediatric Pulmonology, Subcommittee on Obstructive Sleep Apnea Syndrome. American Aca-demy of Pediatrics. Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2002;109(4):704-12.
88 Marcus CL, Rosen G, Ward SL, Halbower AC, Sterni L, Lutz J, et al. Adherence to and effectiveness of positi-ve airway pressure therapy in children with obstructive sleep apnea. Pediatrics. 2006;117(3):e442-51.
89 Marcus CL, Beck SE, Traylor J, Cornaglia MA, Meltzer LJ, DiFeo N, et al. Randomized, double-blind clinical tri-al of two different modes of positive airway pressure therapy on adherence and efficacy in children. J Clin Sleep Med. 2012;8(1):37-42.
90 Machaalani R, Evans CA, Waters KA. Objective adherence to positive airway pressure therapy in an Austra-lian paediatric cohort. Sleep Breath. 2016;20(4):1327-36.
91 Koontz KL, Slifer KJ, Cataldo MD, Marcus CL. Improving pediatric compliance with positive airway pressure therapy: the impact of behavioral intervention. Sleep. 2003;26(8):1010-5.
92 Prashad PS, Marcus CL, Maggs J, Stettler N, Cornaglia MA, Costa P, et al. Investigating reasons for CPAP ad-herence in adolescents: a qualitative approach. J Clin Sleep Med. 2013;9(12):1303-13.
93 Andersen IG, Holm JC, Homøe P. Obstructive sleep apnea in obese children and adolescents, treatment methods and outcome of treatment - a systematic review. Int J Pediatr Otorhinolaryngol. 2016;87:190-7.
94 Kalra M, Inge T. Effect of bariatric surgery on obstructive sleep apnoea in adolescents. Paediatr Respir Rev. 2006;7(4):260-7.
95 Huynh NT, Desplats E, Almeida FR. Orthodontics treatments for managing obstructive sleep apnea syn-drome in children: a systematic review and meta- analysis. Sleep Med Rev. 2016;25:84-94.
96 Picchietti MA, Picchietti DL. Advances in pediatric restless legs syndrome: iron, genetics, diagnosis and trea-tment. Sleep Med. 2010;11(7):643-51.
97 Dosman C, Witmans M, Zwaigenbaum L. Iron's role in paediatric restless legs syndrome - a review. Paediatr Child Health. 2012;17(4):193-7.
98 Mindell JA, Emslie G, Blumer J, Genel M, Glaze D, Ivanenko A, et al. Pharmacologic management of insom-nia in children and adolescents: consensus statement. Pediatrics. 2006;117(6):e1223-32.
99 Picchietti MA, Picchietti DL. Restless legs syndrome and periodic limb movement disorder in children and adolescents. Semin Pediatr Neurol. 2008;15(2):91-9.
100 Aurora RN, Kristo DA, Bista SR, et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep. 2012;35(8):1039-62.
101 England SJ, Picchietti DL, Couvadelli BV, Fisher BC, Siddiqui F, Wagner ML, et al. L-dopa improves Restless Legs Syndrome and periodic limb movements in sleep but not Attention-Deficit- Hyperactivity Di-sorder in a double-blind trial in children. Sleep Med. 2011;12(5):471-7.
102 Amos LB, Grekowicz ML, Kuhn EM, Olstad JD, Collins MM, Norins NA, et al. Treatment of pediatric restless legs syndrome. Clin Pediatr (Phila). 2014;53(4):331-6.
103 Frauscher B, Gschliesser V, Brandauer E, El-Demerdash E, Kaneider M, Rücker L, et al. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels. Sleep Med. 2009;10(6):611-5.
104 Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology. 2007;68(4):301-3.
105 Silber MH, Ehrenberg BL, Allen RP, Buchfuhrer MJ, Earley CJ, Hening WA, et al. An algorithm for the management of restless legs syndrome. Mayo Clin Proc. 2004;79(7):916-22.
106 Simakajornboon N, Dye TJ, Walters AS. Restless legs Syndrome/Willis-Ekbom disease and growing pains in children and adolescents. Sleep Med Clin. 2015;10(3):311-22.
107 Rulong G, Dye T, Simakajornboon N. Pharmacological management of restless legs syndrome and periodic limb movement disorder in children. Paediatr Drugs. 2018;20(1):9-17.
108 Simakajornboon N, Kheirandish-Gozal L, Gozal D. Diagnosis and management of restless legs syn-drome in children. Sleep Med Rev. 2009;13(2):149-56.
109 Kotagal S. Parasomnias in childhood. Sleep Med Rev. 2009;13(2):157-68.
110 Attarian H. Treatment options for parasomnias. Neurol Clin. 2010;8(4):1089-106.
111 Howell MJ. Parasomnias: an updated review. Neurotherapeutics. 2012;9(4):753-75.
112 Tinuper P, Bisulli F, Provini F. The parasomnias: mechanisms and treatment. Epilepsia. 2012;(53 Su-ppl 7):12-9.
113 Pressman MR. Factors that predispose, prime and precipitate NREM parasomnias in adults: clinical and forensic implications. Sleep Med Rev. 2007;11(1):5-30;discussion:31-3.
114 Fleetham JA, Fleming JA. Parasomnias. CMAJ. 2014;186(8):E273-80.
115 Cock VC. Sleepwalking. Curr Treat Options Neurol. 2016;18(2):6.
116 Proserpio P, Terzaghi M, Manni R, Nobili L. Drugs used in parasomnia. Sleep Med Clin. 2018;13(2):191-202.
117 Attarian H, Zhu L. Treatment options for disorders of arousal: a case series. Int J Neurosci. 2013;123(9):623-5.
118 Manni R, Toscano G, Terzaghi M. Therapeutic symptomatic strategies in the parasomnias. Curr Tre-at Options Neurol. 2018;20(7):26.
119 Bruni O, Novelli L. Sleep disorders in children. BMJ Clin Evid. 2010;2304.
120 Rogers AE, Aldrich MS, Lin X. A comparison of three different sleep schedules for reducing daytime sleepiness in narcolepsy. Sleep. 2001;24(4):385-91.
121 Lecendreux M. Pharmacological management of narcolepsy and cataplexy in pediatric patients. Pediatr Drugs. 2014;16(5):363-72.
122 Lecendreux M, Dauvilliers Y, Arnulf I, Franco P. Narcolepsy with cataplexy in the child: clinical evalu-ation and therapeutical management. Rev Neurol (Paris). 2008;164(8-9):646-57.
123 Peterson PC, Husain AM. Pediatric narcolepsy. Brain Dev. 2008;30(10):609-23.
124 Lecendreux M, Bruni O, Franco P, Gringras P, Konofal E, Nevsimalova S, et al. Clinical experience suggests that modafinil is an effective and safe treatment for paediatric narcolepsy. J Sleep Res. 2012;21(4):481-3.
125 Ivanenko A, Tauman R, Gozal D. Modafinil in the treatment of excessive daytime sleepiness in chil-dren. Sleep Med. 2003;4(6):579-82.
126 Lavault S, Dauvilliers Y, Drouot X, Leu-Semenescu S, Golmard JL, Lecendreux M, et al. Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy. Sleep Med. 2011;12(6):550-6.
127 Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002;41(2 Suppl):26S-49S.
128 Nittur N, Konofal E, Dauvilliers Y, Franco P, Leu-Semenescu S, Cock VC, et al. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review. Sleep Med. 2013;14(1):30-6.
129 Morgenthaler TI, Kapur VK, Brown T, Swick TJ, Alessi C, Aurora RN, et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007;30(12):1705-11.
130 Mansukhani MP, Kotagal S. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study. Sleep Med. 2012;13(6):606-10.
131 Lecendreux M, Poli F, Oudiette D, Benazzouz F, Donjacour CEHM, Franceschini C, et al. Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study. Sleep. 2012;35(5):709-11.
132 Plazzi G, Ruoff C, Lecendreux M, Dauvilliers Y, Rosen CL, Black J, et al. Treatment of paediatric nar-colepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation. Lancet Child Adolesc Health. 2018;2(7):483-94.
133 Abad VC. An evaluation of sodium oxybate as a treatment option for narcolepsy. Expert Opin Pharmacother. 2019;20(10):1189-99.
134 Inocente C, Arnulf I, Bastuji H, Thibault-Stoll A, Raoux A, Reimão R, et al. Pitolisant, an inverse ago-nist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with re-fractory sleepiness. Clin Neuropharmacol. 2012;35(2):55-60.
135 Lopez R, Arnulf I, Drouot X, Lecendreux M, Dauvilliers Y. Consensus. Prise en charge thérapeutique des patients hypersomniaques: quelle stratégie?. Médecine du sommeil. 2017;14(3):138-50.
136 Arnulf I, Lecendreux M, Franco P, Dauvilliers Y. Kleine-Levin syndrome: state of the art. Rev Neurol (Paris). 2008;164(8-9):658-68.
137 Arnulf I, Groos E, Dodet P. Kleine-Levin syndrome: a neuropsychiatric disorder. Rev Neurol (Paris). 2018;174(4):216-27.
138 Arnulf I, Rico TJ, Mignot E. Diagnosis, disease course, and management of patients with Kleine-Levin syndrome. Lancet Neurol. 2012;11(10):918-28.
139 Oliveira MM, Conti C, Prado GF. Pharmacological treatment for Kleine-Levin syndrome. Cochrane Database Syst Rev. 2016;(5):CD006685.
140 U.S. Preventive Services Task Force. Screening for depression in children and adolescents: recom-mendation statement. Am Fam Physician. 2016;93(6):506-8.
141 Hussain H, Dubicka B, Wilkinson P. Recent developments in the treatment of major depressive di-sorder in children and adolescents. Evid Based Ment Health. 2018;21(3):101-6.
142 Lewandowski RE, Acri MC, Hoagwood KE, Olfson M, Clarke G, Gardner W, et al. Evidence for the management of adolescent depression. Pediatrics. 2013;132(4):e996-e1009.
143 Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN. Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Database Syst Rev. 2012;11:CD004851.
144 DeFilippis M, Wagner KD. Management of treatment-resistant depression in children and adoles-cents. Paediatr Drugs. 2014;16(5):353-61.
145 Sachs C, Persson HE, Hagenfeldt K. Menstruation-related periodic hypersomnia: a case study with successful treatment. Neurology. 1982;32(12):1376-9.
146 Barateau L, Lopez R, Franchi JA, Dauvilliers Y. Hypersomnolence, hypersomnia, and mood disor-ders. Curr Psychiatry Rep. 2017;19(2):13.
147 Dye TJ, Jain SV, Kothare SV. Central hypersomnia. Semin Pediatr Neurol. 2015;22(2):93-104.
148 Gore R, Chugh PK, Tripathi CD, Lhamo Y, Gautam S. Pediatric off-label and unlicensed drug use and its implications. Curr Clin Pharmacol. 2017;12(1):18-25.
149 Kimland E, Odlind V. Off-label drug use in pediatric patients. Clin Pharmacol Ther. 2012;91(5):796-801.
150 Gruber R, Carrey N, Weiss SK, Frappier JY, Rourke L, Brouillette RT, et al. Position statement on pe-diatric sleep for psychiatrists. J Can Acad Child Adolesc Psychiatry. 2014;23(3):174-95.
151 Pelayo R, Chen W, Monzon S, Guilleminault C. Pediatric sleep pharmacology: you want to give my kid sleeping pills?. Pediatr Clin North Am. 2004;51(1):117-34.